Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension

BACKGROUND: Renin–angiotensin–aldosterone-system inhibitors markedly play an active role in the primary prevention of atrial fibrillation (AF), but the impact of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) on the mortality of patients with AF remains uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wei, Yang, Yan-min, Zhu, Jun, Wu, Shuang, Wang, Juan, Zhang, Han, Shao, Xing-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973677/
https://www.ncbi.nlm.nih.gov/pubmed/35365067
http://dx.doi.org/10.1186/s12872-022-02580-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973677/
https://www.ncbi.nlm.nih.gov/pubmed/35365067
http://dx.doi.org/10.1186/s12872-022-02580-2

Ejemplares similares